BRIEF published on 02/11/2025 at 16:05, 9 months 21 days ago Zentra Group plc: PDMR Dealing and TR1 Notification Voting Rights Share Transaction Zentra Group Jason Upton PDMR Dealing
PRESS RELEASE published on 02/11/2025 at 16:00, 9 months 21 days ago Zentra Group plc: PDMR Dealing and TR1 Notification Zentra Group plc announces PDMR Dealing and TR1 Notification as Director Jason Upton purchases 4,375,000 ordinary shares at £0.04 per share Share Purchase TR1 Notification Jason Upton PDMR Dealing Zentra
BRIEF published on 01/24/2025 at 08:05, 10 months 11 days ago Zentra Group plc: Key Shareholding Notification Voting Rights Major Shareholding Hargreaves Lansdown Zentra Group Jason Upton
PRESS RELEASE published on 01/24/2025 at 08:00, 10 months 11 days ago Zentra Group plc: TR-1: Notification of Major Holdings Zentra Group plc notifies major holdings by Hargreaves Lansdown Asset Management Limited. Non-UK issuer signals an acquisition of voting rights on 9/12/2024 Acquisition Major Holdings Zentra Group PLC Hargreaves Lansdown Asset Management Limited Non-UK Issuer
BRIEF published on 01/08/2025 at 15:35, 10 months 27 days ago Zentra Group Signs New Agreement with Major Shareholder Governance Majority Shareholder Zentra Group Stock Exchange Transition Relationship Agreement
PRESS RELEASE published on 01/08/2025 at 15:30, 10 months 27 days ago Zentra Group plc: New Relationship Agreement Signed with Majority Shareholder Zentra Group plc signs new Relationship Agreement with majority shareholder, reinforcing commitment to transparency and independence amidst transition to Aquis Stock Exchange Transparency Independence Majority Shareholder Zentra Group PLC Relationship Agreement
BRIEF published on 12/11/2024 at 08:05, 11 months 24 days ago Zentra Group plc Transitions to Aquis and Announces Strategic Update Residential Development Strategic Realignment Capital Restructuring Zentra Group Stock Exchange Transition
PRESS RELEASE published on 12/11/2024 at 08:00, 11 months 24 days ago Zentra Group plc: Transition to Aquis and Strategic Update Zentra Group plc transitions to Aquis Stock Exchange from LSE, focusing on residential development. Strategic realignment includes debt restructuring and acquisition. CEO confident in new direction for sustainable growth Acquisition Residential Development Aquis Stock Exchange Debt Restructuring Zentra Group PLC
BRIEF published on 12/09/2024 at 14:21, 11 months 26 days ago Zentra Group Plc: Director Share Purchase Update London Stock Exchange Residential Development Share Purchase Zentra Group PLC Jason Upton
PRESS RELEASE published on 12/09/2024 at 14:16, 11 months 26 days ago Zentra Group plc: Director/PDMR Transaction Zentra Group plc director Jason Upton purchases 141,806 ordinary shares at £0.035 per share, now holding 3.53% of issued share capital Ordinary Shares Share Purchase UK Director Zentra Group PLC
Published on 12/05/2025 at 02:35, 5 hours 13 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 48 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 43 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 48 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 48 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 18 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 57 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 23 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 33 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 48 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 3 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 4 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
